The US Food and Drug Administration has authorised the use of blood plasma as a treatment option for coronavirus patients
The JSE had its best day in almost three weeks on Monday, firming in line with global markets as hope for a Covid-19 treatment supported risk sentiment.
“Markets have naturally been very sensitive to vaccine and treatment developments in recent months and it seems we’re getting a bit of a bump once again,” said Oanda market analyst Craig Erlam.A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Risks in the US bond marketSPONSORED | PSGWealth US bond yields are at 40-year lows, and still investors fall over their feet to snap up more US Treasuries. Read more.
Read more »
Global equity markets up for second session in a rowUS futures have indicated gains ahead for Wall Street, raising the prospect of record highs for the S&P 500
Read more »
JSE set for second day of gains on virus treatment newsGlobal equities rallied on news that the US Food and Drug Administration authorised the use of blood plasma as a treatment for Covid-19
Read more »
Crawley, Buttler, Anderson heap misery on PakistanJames Anderson grabbed three quick wickets as England put the pressure on Pakistan on day two of their third Test in Southampton. | IOLsport
Read more »
Germany’s Sophia Popov claims maiden major at women’s British OpenWorld No 304 started day with a three-shot lead but bogeyed first hole before birdieing second and third
Read more »
Australia COVID-19 case numbers slowAustralia was on course to report its lowest one-day rise in new coronavirus infections in almost two months on Monday.
Read more »